Is Boeing (BA) a Buy Ahead of Q2 2025 Earnings Amid Strengthening Revenues and Elevated Risks?

The Boeing Company (BA) has long been a symbol of American industrial might, but its journey in 2025 has been anything but smooth. After years of crisis, from the 737 MAX grounding to geopolitical headwinds, the aerospace giant is showing signs of stabilization. With its Q2 2025 earnings report due on July 29, 2025, investors are weighing whether Boeing's recent momentum justifies a long-term bet—or if its structural risks outweigh its potential.

Earnings Momentum: A Narrowing Loss and Strong Revenue Growth

Boeing's Q1 2025 results painted a cautiously optimistic picture. The company posted a net loss of $31 million (16 cents per share), a dramatic improvement from a $355 million loss in Q1 2024. Revenue surged 18% to $19.5 billion, driven by a 75% increase in commercial aircraft revenue to $8.15 billion. This growth was fueled by a 57% year-over-year rise in commercial aircraft deliveries (130 units), as production bottlenecks eased and the 737 MAX program accelerated.

Analysts project Q2 2025 revenue of $21.86 billion, a 29.6% year-over-year increase, with commercial airplane revenue expected to hit $9.95 billion. Free cash flow, while still negative, has improved from -$3.9 billion in Q1 2024 to -$2.29 billion in Q1 2025, aligning with management's guidance for positive cash flow in the second half of the year.

Valuation Discounts: A Bargain or a Value Trap?

Boeing's valuation metrics suggest a compelling entry point for patient investors. As of July 2025, the company trades at a price-to-sales (P/S) ratio of 2.51, higher than its historical average of 1.88 but significantly lower than industry peers like Lockheed Martin (1.37) and Northrop Grumman (2.02). Its price-to-book (P/B) ratio is reported at 2.51 (despite conflicting data suggesting a negative P/B of -52.4, likely due to accounting anomalies), indicating the market values its assets at roughly 2.5 times their book value.

However, Boeing's trailing P/E ratio is negative (-13.5), reflecting ongoing losses. For context, Airbus trades at a P/E of 15x, underscoring Boeing's undervaluation relative to its European rival. Analysts like Goldman Sachs and BofA have set price targets of $230–$260, implying a 9%–16% upside from current levels.

Structural Headwinds: Safety, Production, and Geopolitical Risks

Despite Boeing's progress, three major risks loom large:
1. Safety Scrutiny: The June 2025 Air India 787 crash, which killed 270 passengers, has reignited concerns about Boeing's safety culture. Investigations into potential design flaws, fuselage gaps, and whistleblower reports of manufacturing shortcuts could delay regulatory approvals for the 777X and 737 MAX programs.
2. Production Bottlenecks: Engine shortages and FAA inspections are slowing the ramp-up of 737 MAX production to 38 units per month by late 2025. The 777X program, delayed since 2020, now faces certification hurdles pushed to late 2025. A repeat of the 737 MAX grounding could cost Boeing $20 billion.
3. Geopolitical Tensions: U.S.-China trade disputes continue to block Boeing's re-entry into China's $120 billion annual market, where Airbus now holds a 500-aircraft order lead. Meanwhile, Israel-Iran tensions in mid-2025 have spiked oil prices and disrupted global supply chains, threatening Boeing's international supplier network.

Investment Thesis: A High-Risk, High-Reward Play

Boeing's $148 billion market cap is supported by a $545 billion commercial backlog, including Qatar Airways' $96 billion order for 160 twin-aisle aircraft, and $500 billion in defense contracts like the NGAD program. Fitch Ratings upgraded Boeing's credit outlook to “stable” in June 2025, citing improved liquidity and reduced litigation risks after a DOJ settlement.

However, the company's $60 billion in debt and Q1 free cash outflow of $2.29 billion raise red flags. If the Air India crash investigation uncovers systemic flaws, Boeing could face massive liability claims, forcing airlines to shift to Airbus or COMAC.

For investors with a high risk tolerance, Boeing offers a compelling case:
- Upside: Strong revenue growth, a narrowing loss, and a valuation discount relative to peers suggest a potential re-rating if production rates accelerate and regulatory hurdles clear.
- Downside: A repeat of the 737 MAX grounding or a regulatory crackdown on safety practices could trigger a 30%+ stock price drop.

Conclusion: A Calculated Bet Ahead of Q2 Earnings

Boeing's July 29 earnings report will be a critical inflection point. A positive surprise—such as improved margins, production rate progress, or FAA approval for the 777X—could validate the bull case. However, any setbacks in safety investigations or production delays could reignite skepticism.

For now, Boeing presents a high-risk, high-reward opportunity. Patient investors who believe in the company's long-term fundamentals and defense growth may consider a cautious entry, but they should remain vigilant about the risks. As the aerospace giant navigates this pivotal period, the market will be watching closely to see if Boeing can reclaim its place as a leader in global aviation.

"""